
Lucid Diagnostics (LUCD)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Lucid Diagnostics (LUCD) Stock
Start investing in Lucid Diagnostics (LUCD)
About Lucid Diagnostics (LUCD)
Market cap | $139.57M |
Today's volume | 744.91K |
Revenue (TTM) | $4.17M |
Avg. daily volume | 1.2M |
EBITDA (TTM) | -$46.86M |
Open | $1.32 |
Price / earnings ratio | -1.08x |
Today's range | $1.28 - $1.34 |
Debt / equity | — |
52 week range | $0.68 - $1.8 |
5 year debt / equity | 5.86x |
Beta (LTM) | 0.76x |
Interest coverage | -1771.23x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 0.75x |
Ex-dividend date | — |
Next earnings | Aug 11, 2025 |
Dividend payable date | — |
Lucid Diagnostics Stock Rating
Lucid Diagnostics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy LUCD stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in LUCD stock
Navigate to the Explore page. Then, type LUCD into the search bar. When you see LUCD stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased LUCD stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Lucid Diagnostics Stock Earnings
The value each LUCD share was expected to gain vs. the value that each LUCD share actually gained.
Lucid Diagnostics (LUCD) reported Q1 2025 earnings per share (EPS) of -$0.16, missing estimates of -$0.10 by 60.00%. In the same quarter last year, Lucid Diagnostics's earnings per share (EPS) was -$0.21. Lucid Diagnostics is expected to release next earnings on 08/11/2025, with an earnings per share (EPS) estimate of $0.